Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03097458
Other study ID # PP-16-07
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 4, 2017
Est. completion date September 1, 2019

Study information

Verified date July 2020
Source University Hospital, Basel, Switzerland
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A parental cancer diagnosis challenges the family's stability and the parent-child relationship. It may impact the children's well-being, so that about one third of them develop clinically relevant levels of psychological distress. Psycho-oncological family-based counselling programs have been shown to elevate children's and parents' well-being. However, there is still a dearth of familial health services in Switzerland, which has also been recognized by the Swiss National Cancer Program (2011-2017).

This study aims to implement and evaluate a short-term family counselling intervention at the Cancer Center of the University Hospital Basel. The primary objective of the study is the enhancement of adjustment to the parental cancer diagnosis. The study seeks secondary to determine the feasibility of the short-term counselling Intervention.


Description:

This study ist designed as a randomized controlled wait-list Intervention study, which aims to implement and evaluate a short-term family counselling intervention at the Cancer Center of the University Hospital Basel. The study will be divided into two stages: Stage 1 serves as the preparatory work phase, where the intervention manual will be developed as well as the implementation strategy into the hospital. In stage 2 the intervention will be evaluated, with an interim analysis to test for feasibility. The primary objective of the study is the enhancement of adjustment (family, parents and children) to the parental cancer diagnosis. The study seeks secondary to determine the feasibility of the short-term counselling intervention in the Swiss medical setting and to identify predictors for families with continuing psychosocial adjustment problems.


Recruitment information / eligibility

Status Completed
Enrollment 11
Est. completion date September 1, 2019
Est. primary completion date September 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Months and older
Eligibility Inclusion Criteria:

- Informed Consent as documented by signature

- Diagnosis of any kind of cancer, inclusive relapse, within the last year with an expected survival of at least 8 months

- Married, cohabiting or single parent

- At least one child between 1-5 - 18 years

- German speaking

Exclusion Criteria:

- The diagnosis is more than 1 year ago

- Diagnosed patients (parent) not living with their children

- Diagnosed patients without custody of their children

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Short-term Counselling for Families
Counselling for Families which can take up to 6 weeks, with regular meetings under the guidance of a trained psychotherapist.

Locations

Country Name City State
Switzerland University Hospital Basel Basel

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Basel, Switzerland propatient Forschungsstiftung

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of children's quality of life on the health-related quality of life questionnaire (KINDL) Enhancement of children's quality of life from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group. 6 weeks (change between baseline and week 6)
Primary Change of children's behavioral-emotional functioning on the Strengths and Difficulties Questionnaire (SDQ) Enhancement of children's behavioral-emotional functioning from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group. 6 weeks (change between baseline and week 6)
Primary Change of parent's mental health on the Hospital Anxiety and Depression Scale (HADS) Enhancement of parent's mental health from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group. 6 weeks (change between baseline and week 6)
Primary Change of family functioning on the Family Adaptability and Cohesion Evaluation Scale (FACES IV) Enhancement of family functioning from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group. 6 weeks (change between baseline and week 6)
Primary Change of relationship quality on the relationship questionnaire (Partnerschaftsfragebogen PFB) Enhancement of relationship quality from T1 (baseline) to T2 (6 weeks) compared to the wait-list control group. 6 weeks (change between baseline and week 6)
Secondary Number of participants willing to participate in the counselling Secondary outcome will be to determine whether a short-term counselling intervention is feasible in the Swiss medical setting by collecting the number of participants willing to participate. Through study completion, an average of 2 years
Secondary Sociodemographic characteristics (i.e. age, gender, education) of the participants willing to participate in the counselling with the sociodemographic questionnaire Collecting sociodemographic characteristics of the population willing to participate with the sociodemographic questionnaire Through study completion, an average of 2 years
Secondary Medical history characteristics (i.e. cancer diagnosis, cancer treatment) of the participants willing to participate in the counselling with the medical history questionnaire Collecting medical history of the population willing to participate with the medical history questionnaire Through study completion, an average of 2 years
Secondary Dropout rate during the recruitment and intervention procedure Secondary outcome will be to determine whether a short-term counselling intervention is feasible in the Swiss medical setting by collecting dropout rate during the recruitment and intervention procedure. Through study completion, an average of 2 years
Secondary Client satisfaction on the Client Satisfaction Questionnaire (CSQ-8) German Version of the Client Satisfaction Questionnaire: Fragebogen zur Messung der Patientenzufriedenheit (ZUF-8) will be used to measure client's intervention satisfaction. Measures assessed after 6 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients